Wendy L. Macias-Konstantopoulos, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Restraint, Physical | 3 | 2021 | 185 | 1.470 |
Why?
|
Emergency Service, Hospital | 19 | 2024 | 7957 | 1.360 |
Why?
|
Crime Victims | 5 | 2023 | 347 | 1.130 |
Why?
|
Sex Offenses | 4 | 2022 | 357 | 1.070 |
Why?
|
Needle-Exchange Programs | 1 | 2021 | 27 | 0.740 |
Why?
|
Emergency Medicine | 4 | 2024 | 1223 | 0.690 |
Why?
|
Chest Pain | 2 | 2023 | 1101 | 0.680 |
Why?
|
Harm Reduction | 1 | 2021 | 143 | 0.660 |
Why?
|
Drug Users | 1 | 2021 | 134 | 0.650 |
Why?
|
Triage | 2 | 2023 | 997 | 0.620 |
Why?
|
Abortion, Induced | 1 | 2023 | 471 | 0.580 |
Why?
|
Women's Health Services | 1 | 2017 | 88 | 0.550 |
Why?
|
Delivery of Health Care | 5 | 2018 | 5375 | 0.550 |
Why?
|
Substance-Related Disorders | 4 | 2024 | 4423 | 0.540 |
Why?
|
Ethics, Clinical | 1 | 2017 | 101 | 0.530 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 530 | 0.520 |
Why?
|
Women's Health | 2 | 2017 | 2081 | 0.510 |
Why?
|
Violence | 2 | 2023 | 936 | 0.480 |
Why?
|
Survivors | 4 | 2022 | 2383 | 0.450 |
Why?
|
Professional Role | 1 | 2016 | 316 | 0.430 |
Why?
|
Lead Poisoning | 1 | 2016 | 323 | 0.430 |
Why?
|
Antimony Potassium Tartrate | 1 | 2012 | 3 | 0.420 |
Why?
|
Suicide | 1 | 2024 | 1606 | 0.410 |
Why?
|
Self Report | 1 | 2024 | 3773 | 0.410 |
Why?
|
Health Services Accessibility | 6 | 2024 | 5522 | 0.410 |
Why?
|
Emergency Medical Services | 2 | 2023 | 1947 | 0.390 |
Why?
|
Foreign Bodies | 1 | 2016 | 403 | 0.380 |
Why?
|
Substance Abuse Detection | 1 | 2014 | 301 | 0.380 |
Why?
|
Terminology as Topic | 1 | 2018 | 1541 | 0.370 |
Why?
|
West Nile Fever | 1 | 2011 | 77 | 0.370 |
Why?
|
Poisoning | 1 | 2012 | 252 | 0.360 |
Why?
|
Health Services Needs and Demand | 2 | 2021 | 1407 | 0.360 |
Why?
|
Lead | 1 | 2016 | 882 | 0.340 |
Why?
|
Counseling | 1 | 2017 | 1554 | 0.330 |
Why?
|
Public Health | 3 | 2021 | 2680 | 0.300 |
Why?
|
Psychomotor Agitation | 2 | 2024 | 307 | 0.290 |
Why?
|
Curriculum | 3 | 2024 | 3782 | 0.290 |
Why?
|
Vulnerable Populations | 3 | 2021 | 718 | 0.290 |
Why?
|
Health Personnel | 3 | 2017 | 3383 | 0.270 |
Why?
|
Alcoholism | 1 | 2017 | 1981 | 0.270 |
Why?
|
Dyspnea | 2 | 2023 | 1352 | 0.270 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 1889 | 0.270 |
Why?
|
Pericarditis, Constrictive | 1 | 2005 | 46 | 0.250 |
Why?
|
Referral and Consultation | 3 | 2017 | 3628 | 0.250 |
Why?
|
Pericardiectomy | 1 | 2005 | 45 | 0.250 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 5 | 2004 | 500 | 0.250 |
Why?
|
Corpus Striatum | 6 | 2004 | 1225 | 0.250 |
Why?
|
Gynecology | 2 | 2017 | 534 | 0.220 |
Why?
|
Education, Medical, Graduate | 2 | 2022 | 2422 | 0.220 |
Why?
|
Humans | 48 | 2024 | 768970 | 0.220 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 6 | 2004 | 903 | 0.220 |
Why?
|
Clinical Alarms | 1 | 2024 | 61 | 0.210 |
Why?
|
Physician's Role | 2 | 2017 | 926 | 0.210 |
Why?
|
Obstetrics | 2 | 2017 | 682 | 0.210 |
Why?
|
Physical Exertion | 1 | 2005 | 668 | 0.210 |
Why?
|
Social Stigma | 2 | 2019 | 788 | 0.200 |
Why?
|
Human Rights Abuses | 1 | 2012 | 34 | 0.200 |
Why?
|
Domestic Violence | 1 | 2023 | 180 | 0.190 |
Why?
|
Mass Screening | 1 | 2017 | 5457 | 0.190 |
Why?
|
Forensic Medicine | 1 | 2022 | 68 | 0.190 |
Why?
|
Healthcare Disparities | 3 | 2021 | 3421 | 0.190 |
Why?
|
United States | 10 | 2024 | 73186 | 0.180 |
Why?
|
Crime | 1 | 2012 | 206 | 0.180 |
Why?
|
Potassium Chloride | 1 | 2001 | 229 | 0.180 |
Why?
|
Brazil | 1 | 2023 | 1250 | 0.160 |
Why?
|
Pregnancy | 5 | 2024 | 30265 | 0.160 |
Why?
|
Paraguay | 1 | 2018 | 7 | 0.160 |
Why?
|
Internship and Residency | 2 | 2021 | 5956 | 0.160 |
Why?
|
Health Facilities | 1 | 2023 | 577 | 0.150 |
Why?
|
Videoconferencing | 1 | 2020 | 209 | 0.150 |
Why?
|
Peer Group | 1 | 2023 | 698 | 0.150 |
Why?
|
Insulinoma | 1 | 2018 | 122 | 0.150 |
Why?
|
Membrane Potentials | 1 | 2001 | 1090 | 0.140 |
Why?
|
Nurse Practitioners | 1 | 2020 | 271 | 0.140 |
Why?
|
Female | 21 | 2024 | 397515 | 0.140 |
Why?
|
Beneficence | 1 | 2017 | 56 | 0.140 |
Why?
|
Feedback | 1 | 2020 | 799 | 0.140 |
Why?
|
Confusion | 2 | 2018 | 278 | 0.140 |
Why?
|
Adult | 15 | 2024 | 223851 | 0.130 |
Why?
|
Chelation Therapy | 1 | 2016 | 77 | 0.130 |
Why?
|
Air Ambulances | 1 | 2007 | 93 | 0.130 |
Why?
|
Child | 6 | 2024 | 80960 | 0.130 |
Why?
|
Bioethics | 1 | 2017 | 118 | 0.120 |
Why?
|
Alcohol Withdrawal Seizures | 1 | 2015 | 10 | 0.120 |
Why?
|
Acetone | 1 | 2015 | 44 | 0.120 |
Why?
|
Documentation | 1 | 2022 | 917 | 0.120 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2015 | 26 | 0.120 |
Why?
|
Needs Assessment | 2 | 2018 | 1143 | 0.120 |
Why?
|
Gestational Age | 1 | 2023 | 3621 | 0.120 |
Why?
|
Communication Barriers | 1 | 2018 | 419 | 0.120 |
Why?
|
Resource Allocation | 1 | 2017 | 354 | 0.110 |
Why?
|
Personal Autonomy | 1 | 2017 | 315 | 0.110 |
Why?
|
Amphetamine-Related Disorders | 1 | 2014 | 80 | 0.110 |
Why?
|
Disclosure | 1 | 2019 | 755 | 0.110 |
Why?
|
Risk Factors | 6 | 2018 | 74976 | 0.110 |
Why?
|
Mothers | 1 | 2024 | 2209 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3721 | 0.110 |
Why?
|
Receptors, Dopamine D1 | 2 | 2004 | 277 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2018 | 936 | 0.100 |
Why?
|
Calcium Channels, L-Type | 3 | 2004 | 244 | 0.100 |
Why?
|
Tachycardia | 1 | 2015 | 599 | 0.100 |
Why?
|
Social Justice | 1 | 2017 | 486 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 755 | 0.100 |
Why?
|
Infant | 2 | 2024 | 36556 | 0.090 |
Why?
|
Europe | 1 | 2018 | 3441 | 0.090 |
Why?
|
Family Relations | 1 | 2013 | 318 | 0.090 |
Why?
|
Developing Countries | 1 | 2024 | 2911 | 0.090 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 725 | 0.090 |
Why?
|
Patient Transfer | 1 | 2018 | 792 | 0.090 |
Why?
|
Cocaine-Related Disorders | 1 | 2014 | 458 | 0.090 |
Why?
|
Hypoglycemia | 1 | 2018 | 895 | 0.090 |
Why?
|
Child Abuse, Sexual | 1 | 2013 | 401 | 0.090 |
Why?
|
Liver Failure, Acute | 1 | 2012 | 182 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1445 | 0.090 |
Why?
|
Marijuana Abuse | 1 | 2014 | 409 | 0.090 |
Why?
|
Social Medicine | 1 | 2010 | 64 | 0.090 |
Why?
|
Wounds, Gunshot | 1 | 2016 | 588 | 0.090 |
Why?
|
Neurons | 6 | 2004 | 9519 | 0.080 |
Why?
|
Kenya | 2 | 2022 | 758 | 0.080 |
Why?
|
Vomiting | 1 | 2012 | 655 | 0.080 |
Why?
|
Interviews as Topic | 2 | 2013 | 2744 | 0.080 |
Why?
|
Social Environment | 1 | 2013 | 1015 | 0.080 |
Why?
|
Male | 13 | 2024 | 365203 | 0.080 |
Why?
|
Social Support | 1 | 2018 | 2193 | 0.070 |
Why?
|
Research | 1 | 2016 | 1981 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3928 | 0.070 |
Why?
|
Patient Discharge | 1 | 2021 | 3491 | 0.070 |
Why?
|
Calcium Channel Agonists | 3 | 2003 | 26 | 0.070 |
Why?
|
Nifedipine | 2 | 2004 | 220 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 13021 | 0.070 |
Why?
|
Cyclic AMP | 2 | 2003 | 1469 | 0.070 |
Why?
|
Excitatory Amino Acid Antagonists | 4 | 2004 | 451 | 0.070 |
Why?
|
Mental Health Services | 1 | 2018 | 1732 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2016 | 1447 | 0.070 |
Why?
|
Human Rights | 2 | 2022 | 312 | 0.060 |
Why?
|
Patient Care Team | 1 | 2016 | 2528 | 0.060 |
Why?
|
Iowa | 1 | 2024 | 100 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3269 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4045 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1742 | 0.060 |
Why?
|
Calcium | 5 | 2004 | 5792 | 0.060 |
Why?
|
Calcium Channel Blockers | 2 | 2004 | 691 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10592 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3235 | 0.060 |
Why?
|
Health Policy | 1 | 2016 | 2700 | 0.060 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2003 | 56 | 0.060 |
Why?
|
Infant, Newborn | 1 | 2024 | 26428 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2517 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2003 | 492 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3110 | 0.050 |
Why?
|
Enkephalins | 1 | 2003 | 139 | 0.050 |
Why?
|
Opioid-Related Disorders | 1 | 2018 | 2188 | 0.050 |
Why?
|
Renal Dialysis | 1 | 2012 | 1789 | 0.050 |
Why?
|
Physicians | 1 | 2020 | 4607 | 0.050 |
Why?
|
Sexual Behavior | 2 | 2022 | 2200 | 0.050 |
Why?
|
Crisis Intervention | 1 | 2023 | 111 | 0.050 |
Why?
|
Phosphorylation | 6 | 2004 | 8317 | 0.050 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2001 | 18 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2024 | 81903 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4748 | 0.050 |
Why?
|
Serum Response Factor | 1 | 2001 | 78 | 0.050 |
Why?
|
Middle Aged | 6 | 2024 | 223737 | 0.040 |
Why?
|
Pyrroles | 3 | 2003 | 1125 | 0.040 |
Why?
|
Health Status | 1 | 2013 | 4095 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 5443 | 0.040 |
Why?
|
Exercise Tolerance | 1 | 2005 | 846 | 0.040 |
Why?
|
Patient Isolation | 1 | 2021 | 100 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21547 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7861 | 0.040 |
Why?
|
Risk Assessment | 2 | 2020 | 24333 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 794 | 0.040 |
Why?
|
Protein Precursors | 1 | 2003 | 1135 | 0.040 |
Why?
|
Receptors, GABA | 1 | 2001 | 312 | 0.040 |
Why?
|
Antipsychotic Agents | 2 | 2024 | 3081 | 0.040 |
Why?
|
Carboxypeptidases | 1 | 1999 | 121 | 0.040 |
Why?
|
Photography | 1 | 2022 | 537 | 0.040 |
Why?
|
Rats | 7 | 2004 | 23786 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2024 | 1138 | 0.040 |
Why?
|
Glutamic Acid | 2 | 2003 | 1191 | 0.040 |
Why?
|
Adolescent | 2 | 2017 | 89244 | 0.040 |
Why?
|
Job Satisfaction | 1 | 2021 | 548 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1757 | 0.040 |
Why?
|
Dizocilpine Maleate | 3 | 2004 | 171 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1999 | 581 | 0.030 |
Why?
|
Teaching | 1 | 2024 | 1171 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15879 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 6 | 2004 | 8144 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2024 | 1798 | 0.030 |
Why?
|
Cells, Cultured | 5 | 2004 | 19023 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2024 | 1191 | 0.030 |
Why?
|
Housing | 1 | 2021 | 683 | 0.030 |
Why?
|
Health Services Research | 1 | 2023 | 1818 | 0.030 |
Why?
|
Calcium Channels | 1 | 1999 | 624 | 0.030 |
Why?
|
Hyperinsulinism | 1 | 2018 | 402 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2018 | 541 | 0.030 |
Why?
|
Education, Medical, Undergraduate | 1 | 2024 | 1085 | 0.030 |
Why?
|
Stroke | 1 | 2007 | 9756 | 0.030 |
Why?
|
Young Adult | 3 | 2020 | 60131 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1999 | 1616 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2001 | 11932 | 0.030 |
Why?
|
Sulfonamides | 1 | 2003 | 1981 | 0.030 |
Why?
|
Fetus | 1 | 2001 | 1882 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3214 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 2025 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2020 | 807 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3612 | 0.020 |
Why?
|
Leadership | 1 | 2021 | 1396 | 0.020 |
Why?
|
Burnout, Professional | 1 | 2020 | 711 | 0.020 |
Why?
|
Philippines | 1 | 2010 | 95 | 0.020 |
Why?
|
Students, Medical | 1 | 2024 | 1964 | 0.020 |
Why?
|
Hair | 1 | 2014 | 509 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2784 | 0.020 |
Why?
|
Drug Interactions | 2 | 2004 | 1418 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 1998 | 1448 | 0.020 |
Why?
|
Health Promotion | 1 | 2020 | 2210 | 0.020 |
Why?
|
Program Evaluation | 1 | 2007 | 2508 | 0.020 |
Why?
|
Hippocampus | 1 | 2001 | 3782 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9684 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2003 | 1683 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9377 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8894 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14794 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5804 | 0.020 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2004 | 50 | 0.020 |
Why?
|
Aged | 3 | 2024 | 171786 | 0.010 |
Why?
|
Dopamine Antagonists | 1 | 2004 | 284 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20245 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9618 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2007 | 3008 | 0.010 |
Why?
|
Heart Rate | 1 | 2015 | 4217 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8749 | 0.010 |
Why?
|
Animals | 7 | 2004 | 169335 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2003 | 826 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2004 | 461 | 0.010 |
Why?
|
Isoquinolines | 1 | 2003 | 354 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6413 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 481 | 0.010 |
Why?
|
Carcinogens | 1 | 2003 | 453 | 0.010 |
Why?
|
Genes, fos | 1 | 2000 | 176 | 0.010 |
Why?
|
Excitatory Amino Acid Agonists | 1 | 2000 | 142 | 0.010 |
Why?
|
Cycloserine | 1 | 2000 | 118 | 0.010 |
Why?
|
Receptors, Kainic Acid | 1 | 1999 | 91 | 0.010 |
Why?
|
Blood Pressure | 1 | 2015 | 8544 | 0.010 |
Why?
|
Neostriatum | 1 | 2000 | 238 | 0.010 |
Why?
|
Receptors, Glutamate | 1 | 1999 | 229 | 0.010 |
Why?
|
Haloperidol | 1 | 2000 | 394 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2000 | 1553 | 0.010 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 1999 | 90 | 0.010 |
Why?
|
Receptors, AMPA | 1 | 1999 | 334 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 1676 | 0.010 |
Why?
|
Culture Techniques | 1 | 1998 | 530 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2003 | 1750 | 0.010 |
Why?
|
Clozapine | 1 | 2000 | 509 | 0.010 |
Why?
|
Magnesium | 1 | 1999 | 816 | 0.010 |
Why?
|
Benzazepines | 1 | 1998 | 308 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 1647 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5763 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 1998 | 347 | 0.010 |
Why?
|
Time Factors | 1 | 2007 | 40261 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2018 | 20776 | 0.010 |
Why?
|
Zinc | 1 | 1999 | 677 | 0.010 |
Why?
|
Sodium | 1 | 1999 | 1597 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2003 | 2027 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1999 | 3057 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2003 | 3726 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 59739 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36854 | 0.010 |
Why?
|
Dopamine | 1 | 1998 | 1596 | 0.010 |
Why?
|
Binding Sites | 1 | 1999 | 6023 | 0.010 |
Why?
|
Signal Transduction | 2 | 2003 | 23653 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 65480 | 0.000 |
Why?
|